NCT01089270Unknown不适用
Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 80
- 试验地点
- 1
研究概览
简要总结
Parkinson Disease is one of the most common neurodegenerative illnesses. First degree relatives of Parkinson patient are in high risk for developing the disease. We will try to detect early changes in brain metabolism before the appearance of Parkinson symptoms.
Participants: first degree relatives of diagnosed Parkinson patients that carry a gene mutation in either LRRK2 or GBA genes.
The examination results will be given to the participants by a doctor from the neurology department.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 30 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •healthy first degree relatives of diagnosed Parkinson patients
排除标准
- •patients unable to understand and sign an informed consent
- •people with psychiatric disorders or a history of major head trauma
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic CharacteristicsParkinson DiseaseNCT01089283Tel-Aviv Sourasky Medical Center80
已完成
不适用
Establishing 18F PMPBB3 (APN 1607) PET Imaging Markers for Diagnosis of Tauopathy Parkinsonism SyndromesTau Distributions in Patients With Tauopathy Using APN-1607 PET ScanNCT04557865National Taiwan University Hospital68
招募中
不适用
Non-invasive Detection of Volatile Metabolites in Parkinson's DiseaseParkinson DiseaseNCT06453226Imperial College London120
Unknown
不适用
New Biomarkers in Parkinson's DiseaseParkinson DiseaseNCT05150158Neuromed IRCCS60
已完成
不适用
Evaluation of Autonomic, Imaging and Genetic Markers for Parkinson-related Dementia : Longitudinal Assessment of a PD Cohort.Parkinson DiseaseNCT06156917IRCCS San Raffaele100